This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: In2bones USA, LLC. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Adam Mantzaris: Innovating Syndesmosis Treatment
Introduction
Adam Mantzaris is a prominent inventor based in Memphis, TN, recognized for his contributions to medical technology. With a total of two patents, he has focused on developing innovative solutions for complex orthopedic challenges.
Latest Patents
One of Mantzaris's latest patents is his groundbreaking work on a syndesmosis treatment construct. This apparatus and method are designed to be placed into a cinched configuration that effectively presses a first bone against a second bone. The innovation includes a proximal fixator that contacts the first bone and a distal fixator that contacts the second bone. Additionally, a first suture and a second suture are parallelly looped through the proximal fixator and oppositely looped through the distal fixator. The design allows for precise adjustments, with distal ends of the sutures fixated within a washer located between the proximal fixator and the first bone. By pulling the proximal ends, practitioners can cinch the configuration securely, using various suitable suture knots for fixation. This invention marks a significant advancement in surgical techniques for treating syndesmosis injuries.
Career Highlights
Adam Mantzaris currently works at In2bones USA, LLC, where he is dedicated to creating innovative solutions for orthopedic treatments. His expertise and drive have led to successful patent filings and have positioned him as a valuable asset to his company and the field of medical technology.
Collaborations
Throughout his career, Mantzaris has collaborated with talented coworkers, including Rebecca Hawkins Wahl and Brandon Beckendorf. Together, they contribute to the innovative efforts at In2bones USA, enhancing the company's reputation as a leader in orthopedic solutions.
Conclusion
Adam Mantzaris exemplifies the innovative spirit within the medical technology field. His significant contributions, particularly with the syndesmosis treatment construct, highlight his commitment to improving patient outcomes through advanced surgical solutions. As he continues to develop new inventions, Mantzaris remains an influential figure in his industry, paving the way for future advancements in orthopedic care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile